SB 900 (see companion bill HB 5690) – MichiganStatus: Inactive / Dead
Year Introduced: 2018
PROHIBIT MANUFACTURERS FROM CHARGING EXCESSIVE PRICES OR UNCONSCIONABLE INCREASES IN WHOLESALE ACQUISITION COSTS: A manufacturer of prescription drugs that is engaged in the conduct of trade or commerce shall not charge an excessive price for a prescription drug or change the price for a prescription drug in a manner that results in an unconscionable increase in the wholesale acquisition cost of that drug. If the drug consumer protection commission alleges that a manufacturer is charging an excessive price for a prescription drug or that there has been an unconscionable increase in a manufacturer’s wholesale acquisition cost for a prescription drug, the Attorney General must investigate. The Attorney General can bring a class action suit for violations.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.